The acute phase protein α2-macroglobulin induces rat ventricular cardiomyocyte hypertrophy via ERK1,2 and PI3-kinase/Akt pathways

Cardiovascular Research

Volumn 75, Issue 1, 2007, Pages 118-128

  Padmasekar, Manju ^a   Nandigama, Rajender ^a   Wartenberg, Maria ^b,c   Schlüter, Klaus Dieter ^a   Sauer, Heinrich ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b GKSS Research Institute Teltow   (Germany)

^c FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

2 macroglobulin; Acute phase proteins; Cardiac hypertrophy; SERCA

Indexed keywords

ACUTE PHASE PROTEIN; ADENOSINE TRIPHOSPHATASE (CALCIUM); ALPHA 2 MACROGLOBULIN; ALPHA ACTIN; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; CRK ASSOCIATED SUBSTRATE PROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 3; MYOSIN HEAVY CHAIN BETA; MYOSIN LIGHT CHAIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ARTICLE; CALCIUM CELL LEVEL; CELL GROWTH; CELL SIZE; CELL VOLUME; ELECTROSTIMULATION; ENZYME ACTIVATION; GENE EXPRESSION; HEART HYPERTROPHY; HEART MUSCLE CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MICROFLUOROMETRY; MUSCLE CONTRACTILITY; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SARCOPLASMIC RETICULUM; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ALPHA-MACROGLOBULINS; ANDROSTADIENES; ANIMALS; BUTADIENES; CALCIUM; CARDIOMEGALY; CELLS, CULTURED; CHROMONES; ENZYME ACTIVATION; IMMUNOHISTOCHEMISTRY; MALE; MORPHOLINES; NITRILES; PHENYLALANINE; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; SIGNAL TRANSDUCTION; SIROLIMUS;

EID: 34249904441     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2007.03.003     Document Type: Article

References (49)

1. LaMarre J., Wollenberg G.K., Gonias S.L., and Hayes M.A. Cytokine binding and clearance properties of proteinase-activated alpha 2-macroglobulins. Lab Invest 65 (1991) 3-14
2. Tayade C., Esadeg S., Fang Y., and Croy B.A. Functions of alpha 2 macroglobulins in pregnancy. Mol Cell Endocrinol 245 (2005) 60-66
3. Moestrup S.K., Holtet T.L., Etzerodt M., Thogersen H.C., Nykjaer A., Andreasen PA., et al. Alpha 2-macroglobulin-proteinase complexes, plasminogen activator inhibitor type-1-plasminogen activator complexes, and receptor-associated protein bind to a region of the alpha 2-macroglobulin receptor containing a cluster of eight complement-type repeats. J Biol Chem 268 (1993) 13691-13696
4. Strickland D.K., and Ranganathan S. Diverse role of LDL receptor-related protein in the clearance of proteases and in signalling. J Thromb Haemost 1 (2003) 1663-1670
5. Bacskai B.J., Xia M.Q., Strickland D.K., Rebeck G.W., and Hyman B.T. The endocytic receptor protein LRP also mediates neuronal calcium signalling via N-methyl-d-aspartate receptors. Proc Natl Acad Sci U S A 97 (2000) 11551-11556
6. Misra U.K., and Pizzo S.V. Activation of Akt/PDK signalling in macrophages upon binding of receptor-recognized forms of alpha2-macroglobulin to its cellular receptor: effect of silencing the CREB gene. J Cell Biochem 93 (2004) 1020-1032
7. Misra U.K., Deedwania R., and Pizzo S.V. Activation and cross-talk between Akt, NF-kappaB, and unfolded protein response signalling in 1-LN prostate cancer cells consequent to ligation of cell surface-associated GRP78. J Biol Chem 281 (2006) 13694-13707
8. *-induced signalling. Cell Signal 16 (2004) 929-938
9. Rajamanickam C., Sakthivel S., Babu G.J., Lottspeich F., and Kadenbach B. Cardiac isoform of alpha-2 macroglobin, a novel serum protein, may induce cardiac hypertrophy in rats. Basic Res Cardiol 96 (2001) 23-33
10. Mariappan M., Selvamurugan N., and Rajamanickam C. Purification and characterization of a high-molecular-weight protein induced in rat serum during the development of cardiac hypertrophy. Arch Biochem Biophys 281 (1990) 287-297
11. Annapoorani P., Dhandapany P.S., Sadayappan S., Ramasamy S., Rathinavel A., and Selvam G.S. Cardiac isoform of alpha-2 macroglobulin-a new biomarker for myocardial infarcted diabetic patients. Atherosclerosis 186 (2006) 173-176
12. Banbula A., Chang L.S., Beyer W.F., Bohra C.L., Cianciolo G.J., and Pizzo S.V. The properties of rabbit alpha1-macroglobulin upon activation are distinct from those of rabbit and human alpha2-macroglobulins. J Biochem (Tokyo) 138 (2005) 527-537
13. Pinson A., Schluter K.D., Zhou X.J., Schwartz P., Kessler-Icekson G., and Piper H.M. Alpha- and beta-adrenergic stimulation of protein synthesis in cultured adult ventricular cardiomyocytes. J Mol Cell Cardiol 25 (1993) 477-490
14. Langer M., Luttecke D., and Schluter K.D. Mechanism of the positive contractile effect of nitric oxide on rat ventricular cardiomyocytes with positive force/frequency relationship. Pflugers Arch 447 (2003) 289-297
15. Anwar A., Taimor G., Korkususz H., Schreckenberg R., Berndt T., Abdallah Y., et al. PKC-independent signal transduction pathways increase SERCA2 expression in adult rat cardiomyocytes. J Mol Cell Cardiol 39 (2005) 911-919
16. Shioi T., Kang P.M., Douglas P.S., Hampe J., Yballe C.M., Lawitts J., et al. The conserved phosphoinositide 3-kinase pathway determines heart size in mice. EMBO J 19 (2000) 2537-2548
17. Kim Y.K., Kim S.J., Yatani A., Huang Y., Castelli G., Vatner D.E., et al. Mechanism of enhanced cardiac function in mice with hypertrophy induced by overexpressed Akt. J Biol Chem 278 (2003) 47622-47628
18. Rota M., Boni A., Urbanek K., Padin-Iruegas M.E., Kajstura T.J., Fiore G., et al. Nuclear targeting of Akt enhances ventricular function and myocyte contractility. Circ Res 97 (2005) 1332-1341
19. Schoffstall B., Kataoka A., Clark A., and Chase P.B. Effects of rapamycin on cardiac and skeletal muscle contraction and crossbridge cycling. J Pharmacol Exp Ther 312 (2005) 12-18
20. Misra U.K., and Pizzo S.V. Regulation of cytosolic phospholipase A2 activity in macrophages stimulated with receptor-recognized forms of alpha 2-macroglobulin: role in mitogenesis and cell proliferation. J Biol Chem 277 (2002) 4069-4078
21. Misra U.K., and Pizzo S.V. Potentiation of signal transduction mitogenesis and cellular proliferation upon binding of receptor-recognized forms of alpha2-macroglobulin to 1-LN prostate cancer cells. Cell Signal 16 (2004) 487-496
22. Koenig W., and Rosenson R.S. Acute-phase reactants and coronary heart disease. Semin Vasc Med 2 (2002) 417-428
23. Rajan S., Radhakrishnan J., and Rajamanickam C. Direct injection and expression in vivo of full-length cDNA of the cardiac isoform of alpha-2 macroglobulin induces cardiac hypertrophy in the rat heart. Basic Res Cardiol 98 (2003) 39-49
24. Gourine A.V., Gourine V.N., Tesfaigzi Y., Caluwaerts N., Van Leuven F., and Kluger M.J. Role of alpha(2)-macroglobulin in fever and cytokine responses induced by lipopolysaccharide in mice. Am J Physiol Regul Integr Comp Physiol 283 (2002) R218-R226
25. Okubo H., Miyanaga O., Nagano M., Ishibashi H., Kudo J., Ikuta T., et al. Purification and immunological determination of alpha 2-macroglobulin in serum from injured rats. Biochim Biophys Acta 668 (1981) 257-267
26. Northemann W., Andus T., Gross V., and Heinrich P.C. Cell-free synthesis of rat alpha 2-macroglobulin and induction of its mRNA during experimental inflammation. Eur J Biochem 137 (1983) 257-262
27. Schreiber G., Howlett G., Nagashima M., Millership A., Martin H., Urban J., et al. The acute phase response of plasma protein synthesis during experimental inflammation. J Biol Chem 257 (1982) 10271-10277
28. Gliemann J., Davidsen O., Sottrup-Jensen L., and Sonne O. Uptake of rat and human alpha 2-macroglobulin-trypsin complexes into rat and human cells. FEBS Lett 188 (1985) 352-356
29. Crookston K.P., Webb D.J., LaMarre J., and Gonias S.L. Binding of platelet-derived growth factor-BB and transforming growth factor-beta 1 to alpha 2-macroglobulin in vitro and in vivo: comparison of receptor-recognized and non-recognized alpha 2-macroglobulin conformations. Biochem J 293 Pt 2 (1993) 443-450
30. Lillis A.P., Mikhailenko I., and Strickland D.K. Beyond endocytosis: LRP function in cell migration, proliferation and vascular permeability. J Thromb Haemost 3 (2005) 1884-1893
31. Gaultier A., Salicioni A.M., Arandjelovic S., and Gonias S.L. Regulation of the composition of the extracellular matrix by low density lipoprotein receptor-related protein-1: activities based on regulation of mRNA expression. J Biol Chem 281 (2006) 7332-7340
32. Periasamy M., and Huke S. SERCA pump level is a critical determinant of Ca(2+)homeostasis and cardiac contractility. J Mol Cell Cardiol 33 (2001) 1053-1063
33. Kogler H., Schott P., Toischer K., Milting H., Van P.N., Kohlhaas M., et al. Relevance of brain natriuretic peptide in preload-dependent regulation of cardiac sarcoplasmic reticulum Ca2+ ATPase expression. Circulation 113 (2006) 2724-2732
34. Proud C.G. Ras, PI3-kinase and mTOR signalling in cardiac hypertrophy. Cardiovasc Res 63 (2004) 403-413
35. Wang J., Xu N., Feng X., Hou N., Zhang J., Cheng X., et al. Targeted disruption of Smad4 in cardiomyocytes results in cardiac hypertrophy and heart failure. Circ Res 97 (2005) 821-828
36. Condorelli G., Drusco A., Stassi G., Bellacosa A., Roncarati R., Iaccarino G., et al. Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice. Proc Natl Acad Sci U S A 99 (2002) 12333-12338
37. Matsui T., Li L., Wu J.C., Cook S.A., Nagoshi T., Picard M.H., et al. Phenotypic spectrum caused by transgenic overexpression of activated Akt in the heart. J Biol Chem 277 (2002) 22896-22901
38. Chandrasekar B., Mummidi S., Claycomb W.C., Mestril R., and Nemer M. Interleukin-18 is a pro-hypertrophic cytokine that acts through a phosphatidylinositol 3-kinase-phosphoinositide-dependent kinase-1-Akt-GATA4 signalling pathway in cardiomyocytes. J Biol Chem 280 (2005) 4553-4567
39. Barac Y.D., Zeevi-Levin N., Yaniv G., Reiter I., Milman F., Shilkrut M., et al. The 1,4,5-inositol trisphosphate pathway is a key component in Fas-mediated hypertrophy in neonatal rat ventricular myocytes. Cardiovasc Res 68 (2005) 75-86
40. Hiraoka E., Kawashima S., Takahashi T., Rikitake Y., Hirase T., and Yokoyama M. PI 3-kinase-Akt-p70 S6 kinase in hypertrophic responses to leukemia inhibitory factor in cardiac myocytes. Kobe J Med Sci 49 (2003) 25-37
41. Shiojima I., Sato K., Izumiya Y., Schiekofer S., Ito M., Liao R., et al. Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J Clin Invest 115 (2005) 2108-2118
42. Schiekofer S., Shiojima I., Sato K., Galasso G., Oshima Y., and Walsh K. Microarray analysis of Akt1 activation in transgenic mouse hearts reveals transcript expression profiles associated with compensatory hypertrophy and failure. Physiol Genomics 27 (2006) 156-170
43. McMullen J.R., Sherwood M.C., Tarnavski O., Zhang L., Dorfman A.L., Shioi T., et al. Inhibition of mTOR signalling with rapamycin regresses established cardiac hypertrophy induced by pressure overload. Circulation 109 (2004) 3050-3055
44. Shioi T., McMullen J.R., Tarnavski O., Converso K., Sherwood M.C., Manning W.J., et al. Rapamycin attenuates load-induced cardiac hypertrophy in mice. Circulation 107 (2003) 1664-1670
45. Ha T., Li Y., Hua F., Ma J., Gao X., Kelley J., et al. Reduced cardiac hypertrophy in toll-like receptor 4-deficient mice following pressure overload. Cardiovasc Res 68 (2005) 224-234
46. Rathinavel A., Dhandapany P.S., Annapoorani P., Ramasamy S., and Selvam G.S. Cardiac isoform of alpha-2 macroglobulin as a novel diagnostic marker for cardiac diseases. Eur J Cardiovasc Prev Rehabil 12 (2005) 601-603
47. Mori T., Sasaki J., Kawaguchi H., Handa K., Takada Y., Matsunaga A., et al. Serum glycoproteins and severity of coronary atherosclerosis. Am Heart J 129 (1995) 234-238
48. Pakala R., Stabile E., Jang G.J., Clavijo L., and Waksman R. Rapamycin attenuates atherosclerotic plaque progression in apolipoprotein E knockout mice: inhibitory effect on monocyte chemotaxis. J Cardiovasc Pharmacol 46 (2005) 481-486
49. Liistro F., Fineschi M., Angioli P., Sinicropi G., Falsini G., Gori T., et al. Effectiveness and safety of sirolimus stent implantation for coronary in-stent restenosis: the TRUE (Tuscany Registry of Sirolimus for Unselected In-Stent Restenosis) Registry. J Am Coll Cardiol 48 (2006) 270-275